Varakorn KosaisaveeRossarin SuwanaruskFrançois NostenDennis E. KyleMarion BarrendsJames JonesRic PriceBruce RussellUsa Lek-UthaiMahidol UniversityMenzies School of Health ResearchShoklo Malaria Research UnitWalter Reed Army Institute of ResearchArmed Forces Research Institute of Medical Sciences, Thailand2018-08-202018-08-202006-09-01Experimental Parasitology. Vol.114, No.1 (2006), 34-3910902449001448942-s2.0-33746874044https://repository.li.mahidol.ac.th/handle/20.500.14594/23309In vitro susceptibility tests provide information on the intrinsic response of Plasmodium vivax to antimalarials, free from confounding factors such as host immunity or relapse. This study examined the utility of radioisotope and PicoGreen assays as alternatives to the traditional microscopic examination for assessing response of P. vivax to antimalarial drugs. There was no significant difference in the mean chloroquine IC50of P. vivax (n = 40) as determined by the microscopic (33.4 ng/ml), isotopic (33.6 ng/ml), and PicoGreen (39.1 ng/ml) assays, respectively (F = 0.239, df = 2, 51, and p = 0.788). However measurement of IC50s by the microscopic method was slightly more successful in producing valid assays (57%), compared to the isotopic (32.5%) and PicoGreen (45.5%) methods. In a paired comparison of 20 fresh and cryopreserved isolates as examined by the microscopic method, there were no significant differences between the mean IC50responses (T = 1.58, df = 15, and p = 0.34). Detailed methodologies for the short time culture of field and cryopreserved P. vivax are described. Although the microscopic in vitro assay provides a useful method for characterizing the drug susceptibility phenotype of P. vivax isolates, its utility is limited by a laborious methodology and need for highly skilled microscopists. Future efforts should focus on further development of high throughput assays such as the PicoGreen assay as described in this study. © 2006 Elsevier Inc. All rights reserved.Mahidol UniversityImmunology and MicrobiologyArticleSCOPUS10.1016/j.exppara.2006.02.006